201e Biological Disease Modifying Drugs
- Year:2018
- Document Type:Clinical Commissioning Policy
- Clinical Support area:Rheumatology
- Clinical Service area:Rheumatology
- Synonyms:
- rheumatoid arthritis
- arthritis
- RA
- disease modifying drugs
- biologic
- biosimilar
- immunomodulatory
- JAK inhibitor
- IL6 inhibitor
- DMARD
- methotrexate
- adalimumab
- entanercept
- infliximab
- certolizumab
- golimumab
- tocilizumab
- abatacept
- rituximab
- sarilumab
- tofacitinib